Active	Status	Sponsor type	Region	Phase	Filter
1 Active 3 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Behrens, Frank
PASTOR, NCT04062695 / 2018-004254-22: Tofacitinib for Reduction of Spinal Inflammation in Patients With Psoriatic ArthritiS PresenTing With Axial InvOlvement	Recruiting	2	80	Europe	Tofacitinib 5 MG Oral Tablet [Xeljanz], Xeljanz, Placebo oral tablet	Charite University, Berlin, Germany, Pfizer Pharma GmbH, unrestricted grant	Psoriatic Arthritis, Spondylitis, Sacroilitis	12/23	12/23
Henkemeier, Ulf
No trials found